Efficacy and safety of enteric coated capsules of anise oil to treat irritable bowel syndrome

Journal of Ethnopharmacology

Volumn 194, Issue , 2016, Pages 937-946

  Mosaffa Jahromi, Maryam ^a   Lankarani, Kamran Bagheri ^b   Pasalar, Mehdi ^a   Afsharypuor, Suleiman ^c   Tamaddon, Ali Mohammad ^d  

^a SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c ISFAHAN UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d SHIRAZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Anise oil; Clinical improvement; Enteric coated capsule; Irritable bowel syndrome; Traditional Persian Medicine

Indexed keywords

ANISE OIL; PEPPERMINT OIL; PLACEBO; ESSENTIAL OIL; MICROCAPSULE; VEGETABLE OIL;

ABDOMINAL DISCOMFORT; ABDOMINAL PAIN; ADULT; ALLERGIC REACTION; ALOPECIA; ANOREXIA; ARTICLE; ATAXIA; BLOATING; BLOOD PRESSURE; BURNING SENSATION; COMPARATIVE EFFECTIVENESS; CONSTIPATION; CONTROLLED STUDY; DEFECATION; DEFECATION DISORDER; DEMOGRAPHY; DIARRHEA; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG FEVER; DRUG SAFETY; DYSPEPSIA; ENTERIC COATED TABLET; ERYTHEMA; FATIGUE; FEMALE; FLATULENCE; FOLLOW UP; GASTROESOPHAGEAL REFLUX; HALITOSIS; HEADACHE; HEARTBURN; HUMAN; HYPERSENSITIVITY; HYPERTENSION; HYPOTENSION; INDIGESTION; IRRITABLE COLON; LOSS OF APPETITE; MAJOR CLINICAL STUDY; MALE; MICROCAPSULE; MOUTH DISEASE; MUCOSA INFLAMMATION; MUSCLE DISEASE; NAUSEA; OUTCOME ASSESSMENT; PAIN; PATIENT SATISFACTION; QUALITY OF LIFE; QUALITY OF LIFE ASSESSMENT; RANDOMIZED CONTROLLED TRIAL; STOMATITIS; TREATMENT DURATION; TREMOR; VISUAL ANALOG SCALE; VOMITING; CHEMISTRY; CLINICAL TRIAL; IRRITABLE BOWEL SYNDROME; PILOT STUDY; PIMPINELLA; QUESTIONNAIRE; THERAPEUTIC USE; TREATMENT OUTCOME;

ADULT; CAPSULES; DOUBLE-BLIND METHOD; FEMALE; HUMANS; IRRITABLE BOWEL SYNDROME; MALE; OILS, VOLATILE; PILOT PROJECTS; PIMPINELLA; PLANT OILS; QUALITY OF LIFE; SURVEYS AND QUESTIONNAIRES; TREATMENT OUTCOME;

EID: 85004115648     PISSN: 03788741     EISSN: 18727573     Source Type: Journal    
DOI: 10.1016/j.jep.2016.10.083     Document Type: Article

References (66)

1. Aghili Shirazi, M.H., Qarabadin-e Kabir (Great Pharmacopoeia). 1970, Institute of Meical History, Islamic Medicine and Complementary Medicine; Iran Medical University, Tehran.
2. Aghili Shirazi, M.H., Moalejat-e Aghili (Persian). 2008, Institute of Meical History, Islamic Medicine and Complementary Medicine; Iran Medical University, Tehran.
3. Aghili Shirazi, M.H., Makhzan-al-advia (Persian). 2009, Tehran University of Medical Sciences, Tehran.
4. Al-Bayati, F.A., Synergistic antibacterial activity between Thymus vulgaris and Pimpinella anisum essential oils and methanol extracts. J. Ethnopharmacol. 116:3 (2008), 403–406.
5. Ateş, D.A., Turgay, Ö., Antimicrobial activities of various medicinal and commercial plant extracts. Turk. J. Biol. 27:3 (2003), 157–162.
6. Avicenna, Al Qanun Fi Al-Tibb (Persian), 1988, Soroush Press, Tehran.
7. Bagheri-Lankarani, K., Kodjori, J., Agah, S., Taghavi, S., Rodgari, A., Afrokhteh, S., Irritable bowel syndrome: clinical manifestations and relation to lactase deficiency. Irn. J. Med Sci. 22 (1997), 20–25.
8. Cepae, B.A., WHO monographs on selected medicinal plants. 2007, World Health Organization, Geneva.
9. Chang, L., Ameen, V.Z., Dukes, G.E., McSorley, D.J., Carter, E.G., Mayer, E.A., A dose-ranging, phase II study of the efficacy and safety of alosetron in men with diarrhea-predominant IBS. Am. J. Gastroenterol. 100:1 (2005), 115–123.
10. Clave, P., Acalovschi, M., Triantafillidis, J.K., Uspensky, Y.P., Kalayci, C., Shee, V., Tack, J., Randomised clinical trial: otilonium bromide improves frequency of abdominal pain, severity of distention and time to relapse in patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 34:4 (2011), 432–442.
11. Clevenger, J.F., Apparatus for the determination of volatile oil. J. Am. Pharm. Assoc. 17:4 (1928), 345–349.
12. Commission, B.P., 2011. British Pharmacopoeia 2009.
13. Cremonini, F., Delgado-Aros, S., Camilleri, M., Efficacy of alosetron in irritable bowel syndrome: a meta-analysis of randomized controlled trials. Neurogastroenterol. Motil. 15:1 (2003), 79–86.
14. Cremonini, F., Nicandro, J.P., Atkinson, V., Shringarpure, R., Chuang, E., Lembo, A., Randomised clinical trial: alosetron improves quality of life and reduces restriction of daily activities in women with severe diarrhoea-predominant IBS. Aliment. Pharmacol. Ther. 36:5 (2012), 437–448.
15. Dorn, S.D., Kaptchuk, T.J., Park, J.B., Nguyen, L.T., Canenguez, K., Nam, B.H., Woods, K.B., Conboy, L.A., Stason, W.B., Lembo, A.J., A meta-analysis of the placebo response in complementary and alternative medicine trials of irritable bowel syndrome. Neurogastroenterol. Motil. 19:8 (2007), 630–637.
16. El-Deek, A., Attia, Y., Hannfy, M.M., Short Communication Effect of anise (Pimpinella anisum), ginger (Zingiber of-ficinale roscoe) and fennel (Foeniculum vulgare) and their mixture on performance of broilers. Arch. Geflu¨gelk 67:2 (2002), 92–96.
17. El-Hassan, H., McKeown, K., Muller, A.F., Clinical trial: music reduces anxiety levels in patients attending for endoscopy. Aliment. Pharmacol. Ther. 30:7 (2009), 718–724.
18. George, A.M., Meyers, N.L., Hickling, R.I., Clinical trial: renzapride therapy for constipation-predominant irritable bowel syndrome-multicentre, randomized, placebo-controlled, double-blind study in primary healthcare setting. Aliment. Pharmacol. Ther. 27:9 (2008), 830–837.
19. Gilligan, N.P., The palliation of nausea in hospice and palliative care patients with essential oils of Pimpinella anisum (aniseed), Foeniculum vulgare var. dulce (sweet fennel), Anthemis nobilis (Roman chamomile) and Mentha x piperita (peppermint). Int. J. Aroma 15:4 (2005), 163–167.
20. Greenberger, N., Blumberg, R., Burakoff, R., Current Diagnosis & Treatment Gastroenterology, Hepatology, & Endoscopy. 2011, McGraw Hill Professional, Boston, Massachusetts, USA.
21. Gülçın, İ., Oktay, M., Kıreçcı, E., Küfrevıoǧlu, Ö.İ., Screening of antioxidant and antimicrobial activities of anise (Pimpinella anisum L.) seed extracts. Food Chem. 83:3 (2003), 371–382.
22. Hellstrom, P.M., Hein, J., Bytzer, P., Bjornsson, E., Kristensen, J., Schambye, H., Clinical trial: the glucagon-like peptide-1 analogue ROSE-010 for management of acute pain in patients with irritable bowel syndrome: a randomized, placebo-controlled, double-blind study. Aliment. Pharmacol. Ther. 29:2 (2009), 198–206.
23. Hutchings, H.A., Wareham, K., Baxter, J.N., Atherton, P., Kingham, J.G., Duane, P., Thomas, L., Thomas, M., Ch'ng, C.L., Williams, J.G., A Randomised, Cross-Over, Placebo-Controlled Study of Aloe vera in Patients with Irritable Bowel Syndrome: Effects on Patient Quality of Life. ISRN Gastroenterol., 2011, 2011, 206103.
24. Ibn al-Nafis, A., Al-Shamel fi Sana'at al-Tibbiyah (Arabic). 2008, Institute of Meical History, Islamic Medicine and Complementary Medicine; Iran Medical University, Tehran.
25. Jamshidzadeh, A., Heidari, R., Razmjou, M., Karimi, F., Moein, M.R., Farshad, O., Akbarizadeh, A.R., Shayesteh, M.R., An in vivo and in vitro investigation on hepatoprotective effects of Pimpinella anisum seed essential oil and extracts against carbon tetrachloride-induced toxicity. Iran. J. Basic Med. Sci. 18:2 (2015), 205–211.
26. Jowkar, F., Jamshidzadeh, A., Mirzadeh Yazdi, A., Pasalar, M., The effects of Fumaria parviflora L extract on chronic hand eczema: a randomized double-blind placebo controlled clinical trial. Iran. Red. Crescent Med. J. 13:11 (2011), 824–828.
27. Kang, P., Kim, K.Y., Lee, H.S., Min, S.S., Seol, G.H., Anti-inflammatory effects of anethole in lipopolysaccharide-induced acute lung injury in mice. Life Sci., 2013.
28. Karimzadeh, F., Hosseini, M., Mangeng, D., Alavi, H., Hassanzadeh, G.R., Bayat, M., Jafarian, M., Kazemi, H., Gorji, A., Anticonvulsant and neuroprotective effects of Pimpinella anisum in rat brain. BMC Complement. Altern. Med., 12, 2012, 76.
29. Koloski, N.A., Boyce, P.M., Jones, M.P., Talley, N.J., What level of IBS symptoms drives impairment in health-related quality of life in community subjects with irritable bowel syndrome? Are current IBS symptom thresholds clinically meaningful?. Qual. Life Res. 21:5 (2012), 829–836.
30. Koriem, K.M.M., Approach to pharmacological and clinical applications of Anisi aetheroleum. Asian Pac. J. Trop. Biomed. 5:1 (2015), 60–67.
31. Kosalec, I., Pepeljnjak, S., Kustrak, D., Antifungal activity of fluid extract and essential oil from anise fruits (Pimpinella anisum L., Apiaceae). Acta Pharm. 55:4 (2005), 377–385.
32. Labus, J., Gupta, A., Gill, H.K., Posserud, I., Mayer, M., Raeen, H., Bolus, R., Simren, M., Naliboff, B.D., Mayer, E.A., Randomised clinical trial: symptoms of the irritable bowel syndrome are improved by a psycho-education group intervention. Aliment. Pharmacol. Ther. 37:3 (2013), 304–315.
33. Leventer, S.M., Raudibaugh, K., Frissora, C.L., Kassem, N., Keogh, J.C., Phillips, J., Mangel, A.W., Clinical trial: dextofisopam in the treatment of patients with diarrhoea-predominant or alternating irritable bowel syndrome. Aliment. Pharmacol. Ther. 27:2 (2008), 197–206.
34. Mangel, A.W., Bornstein, J.D., Hamm, L.R., Buda, J., Wang, J., Irish, W., Urso, D., Clinical trial: asimadoline in the treatment of patients with irritable bowel syndrome. Aliment. Pharmacol. Ther. 28:2 (2008), 239–249.
35. Mosaffa-Jahromi, M., Pasalar, M., Afsharypuor, S., Choopani, R., Mosaddegh, M., Kamalinejad, M., Mohagheghzadeh, A., Tamaddon, A.M., Lankarani, K.B., Preventive care for gastrointestinal disorders; role of herbal medicines in traditional persian medicine. Jundishapur J. Nat. Pharm. Prod., 10(4), 2015, e21029.
36. Omidbaigi, R., Hadjiakhoondi, A., Saharkhiz, M., Changes in content and chemical composition of Pimpinella anisum oil at various harvest time. J. Ess. Oil Bear. Plant 6:1 (2003), 46–50.
37. Orav, A., Raal, A., Arak, E., Essential oil composition of Pimpinella anisum L. fruits from various European countries. Nat. Prod. Res. 22:3 (2008), 227–232.
38. Özcan, M., Chalchat, J., Chemical composition and antifungal effect of anise (Pimpinella anisum L.) fruit oil at ripening stage. Ann. Microbiol 56:4 (2006), 353–358.
39. Pasalar, M., Choopani, R., Mosaddegh, M., Kamalinejad, M., Mohagheghzadeh, A., Fattahi, M.R., Ghanizadeh, A., Bagheri Lankarani, K., Efficacy and safety of jollab to treat functional dyspepsia: a randomized placebo-controlled clinical trial. Explore ( N. Y. ) 11:3 (2015), 199–207.
40. Patel, S.M., Stason, W.B., Legedza, A., Ock, S.M., Kaptchuk, T.J., Conboy, L., Canenguez, K., Park, J.K., Kelly, E., Jacobson, E., Kerr, C.E., Lembo, A.J., The placebo effect in irritable bowel syndrome trials: a meta-analysis. Neurogastroenterol. Motil. 17:3 (2005), 332–340.
41. Patrick, D.L., Drossman, D.A., Frederick, I.O., DiCesare, J., Puder, K.L., Quality of life in persons with irritable bowel syndrome: development and validation of a new measure. Dig. Dis. Sci. 43:2 (1998), 400–411.
42. Pourgholami, M.H., Majzoob, S., Javadi, M., Kamalinejad, M., Fanaee, G.H., Sayyah, M., The fruit essential oil of Pimpinella anisum exerts anticonvulsant effects in mice. J. Ethnopharmacol. 66:2 (1999), 211–215.
43. Quigley, E.M., Tack, J., Chey, W.D., Rao, S.S., Fortea, J., Falques, M., Diaz, C., Shiff, S.J., Currie, M.G., Johnston, J.M., Randomised clinical trials: linaclotide phase 3 studies in IBS-C - a prespecified further analysis based on European Medicines Agency-specified endpoints. Aliment. Pharmacol. Ther. 37:1 (2013), 49–61.
44. Rahimi, R., Abdollahi, M., Herbal medicines for the management of irritable bowel syndrome: a comprehensive review. World J. Gastroenterol., 18(7), 2012, 589.
45. Sahib, A.S., Treatment of irritable bowel syndrome using a selected herbal combination of iraqi folk medicines. J. Ethnopharmacol. 148:3 (2013), 1008–1012.
46. Sahraei, H., Ghoshooni, H., Hossein Salimi, S., Mohseni Astani, A., Shafaghi, B., Falahi, M., Kamalnegad, M., The effects of fruit essential oil of the Pimpinella anisum on acquisition and expression of morphine induced conditioned place preference in mice. J. Ethnopharmacol. 80:1 (2002), 43–47.
47. Sallon, S., Ben-Arye, E., Davidson, R., Shapiro, H., Ginsberg, G., Ligumsky, M., A novel treatment for constipation-predominant irritable bowel syndrome using Padma Lax, a Tibetan herbal formula. Digestion 65:3 (2002), 161–171.
48. Samojlik, I., Mijatovic, V., Petkovic, S., Skrbic, B., Bozin, B., The influence of essential oil of aniseed (Pimpinella anisum, L.) on drug effects on the central nervous system. Fitoterapia 83:8 (2012), 1466–1473.
49. Sayuk, G.S., Gyawali, C.P., Irritable bowel syndrome: modern concepts and management options. Am. J. Med. 128:8 (2015), 817–827.
50. Schneider, A., Enck, P., Streitberger, K., Weiland, C., Bagheri, S., Witte, S., Friederich, H.C., Herzog, W., Zipfel, S., Acupuncture TREATMENT in irritable bowel syndrome. Gut 55:5 (2006), 649–654.
51. Schulz, K.F., Altman, D.G., Moher, D., CONSORT 2010 statement: updated guidelines for reporting parallel group randomised trials. Int. J. Surg. 9:8 (2011), 672–677.
52. Shah, E., Pimentel, M., Evaluating the functional net value of pharmacologic agents in treating irritable bowel syndrome. Aliment. Pharmacol. Ther. 39:9 (2014), 973–983.
53. Shojaii, A., Abdollahi Fard, M., Review of pharmacological properties and chemical constituents of Pimpinella anisum. ISRN Pharm., 2012, 2012, 510795.
54. Silk, D.B., Davis, A., Vulevic, J., Tzortzis, G., Gibson, G.R., Clinical trial: the effects of a trans-galactooligosaccharide prebiotic on faecal microbiota and symptoms in irritable bowel syndrome. Aliment. Pharmacol. Ther. 29:5 (2009), 508–518.
55. Simren, M., Ohman, L., Olsson, J., Svensson, U., Ohlson, K., Posserud, I., Strid, H., Clinical trial: the effects of a fermented milk containing three probiotic bacteria in patients with irritable bowel syndrome - a randomized, double-blind, controlled study. Aliment. Pharmacol. Ther. 31:2 (2010), 218–227.
56. Soni, H., The Complete Drug Reference–38th edition, 28, 2014, Nursing Standard, London, UK, 32 (47).
57. Steinhoff, B., E/S/C/O/P-the European Scientific Cooperative on Phytotherapy. Phytomedicine, 9(5), 2002, 485.
58. Su, A.M., Shih, W., Presson, A.P., Chang, L., Characterization of symptoms in irritable bowel syndrome with mixed bowel habit pattern. Neurogastroenterol. Motil. 26:1 (2014), 36–45.
59. Tabanca, N., Bedir, E., Ferreira, D., Slade, D., Wedge, D.E., Jacob, M.R., Khan, S.I., Kirimer, N., Baser, K.H., Khan, I.A., Bioactive constituents from Turkish Pimpinella species. Chem. Biodivers. 2:2 (2005), 221–232.
60. Tack, J.F., Miner, P.B. Jr., Fischer, L., Harris, M.S., Randomised clinical trial: the safety and efficacy of AST-120 in non-constipating irritable bowel syndrome - a double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 34:8 (2011), 868–877.
61. Tafaroj Norooz, A., Tale-Zadeh-Shirazi, H., 2004. Evaluation the efficacy of an Iranian traditional medication on Irritable Bowel Syndrome, Faculty of Medicine Shiraz University of Medical Sciences.
62. Tirapelli, C.R., de Andrade, C.R., Cassano, A.O., De Souza, F.A., Ambrosio, S.R., da Costa, F.B., de Oliveira, A.M., Antispasmodic and relaxant effects of the hidroalcoholic extract of Pimpinella anisum (Apiaceae) on rat anococcygeus smooth muscle. J. Ethnopharmacol. 110:1 (2007), 23–29.
63. Ullah, H., Mahmood, A., Honermeier, B., Essential oil and composition of anise (Pimpinella anisum l.) with varying seed rates and row spacing. Pak. J. Bot. 46:5 (2014), 1859–1864.
64. Wittmann, T., Paradowski, L., Ducrotte, P., Bueno, L., Andro Delestrain, M.C., Clinical trial: the efficacy of alverine citrate/simeticone combination on abdominal pain/discomfort in irritable bowel syndrome-a randomized, double-blind, placebo-controlled study. Aliment. Pharmacol. Ther. 31:6 (2010), 615–624.
65. Xiao, H.T., Zhong, L., Tsang, S.W., Lin, Z.S., Bian, Z.X., Traditional Chinese medicine formulas for irritable bowel syndrome: from ancient wisdoms to scientific understandings. Am. J. Chin. Med. 43:1 (2015), 1–23.
66. Zhang, L.-G., Zhang, C., Ni, L.-J., Yang, Y.-J., Wang, C.-M., Rectification extraction of Chinese herbs' volatile oils and comparison with conventional steam distillation. Sep. Purif. Technol. 77:2 (2011), 261–268.